Identifying subset of genes that have influential impacts on cancer progression: a new approach to analyze cancer microarray data.
Cancer is a complex genetic disease, resulting from defects of multiple genes. Development of microarray techniques makes it possible to survey the whole genome and detect genes that have influential impacts on the progression of cancer. Statistical analysis of cancer microarray data is challenging because of the high dimensionality and cluster nature of gene expressions. Here, clusters are composed of genes with coordinated pathological functions and/or correlated expressions. In this article, we consider cancer studies where censored survival endpoint is measured along with microarray gene expressions. We propose a hybrid clustering approach, which uses both pathological pathway information retrieved from KEGG and statistical correlations of gene expressions, to construct gene clusters. Cancer survival time is modeled as a linear function of gene expressions. We adopt the clustering threshold gradient directed regularization (CTGDR) method for simultaneous gene cluster selection, within-cluster gene selection, and predictive model building. Analysis of two lymphoma studies shows that the proposed approach - which is composed of the hybrid gene clustering, linear regression model for survival, and clustering regularized estimation with CTGDR - can effectively identify gene clusters and genes within selected clusters that have satisfactory predictive power for censored cancer survival outcomes.